Viewing Study NCT05690204


Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2025-12-29 @ 1:20 AM
Study NCT ID: NCT05690204
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-14
First Post: 2022-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
Sponsor: Shanton Pharma Pte. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module